Incidence of adverse reactions to vaccines in a paediatric population

Pilar Carrasco-Garrido1, Carmen Gallardo-Pino, Rodrigo Jiménez-García

  • 1Preventive Medicine and Public Health Teaching and Research Unit, Faculty of Health Sciences, Rey Juan Carlos University, Alcorcón, Spain.

Insights

This study detected non-serious adverse reactions in 19% of children receiving vaccines, with the diphtheria, tetanus, pertussis acellular and Haemophilus influenzae type b (DTPa + Hib) vaccine most frequently implicated. Healthcare providers should actively monitor for vaccine side effects in pediatric populations.

Area of Science:

  • Pediatric Vaccinology
  • Epidemiological Studies
  • Public Health

Background:

  • Vaccine safety monitoring is crucial for public trust and informed decision-making.
  • Understanding the spectrum of adverse reactions in children is essential for healthcare providers.
  • Previous studies may not capture all vaccine-related adverse events in pediatric populations.

Purpose of the Study:

  • To actively detect and characterize adverse reactions following vaccination in a pediatric cohort.
  • To identify specific vaccine types associated with common adverse events.
  • To inform healthcare professionals about potential vaccine side effects in children.

Main Methods:

  • A 6-month prospective, observational, multicenter study involving 946 children aged 0-14 years.
  • Two-phase telephone surveys conducted at 1 week and 30 days post-vaccination.
  • Adverse reactions were diagnosed by a pediatrician.

Main Results:

  • 191 non-serious adverse reactions were reported in 19% of vaccinated children.
  • The diphtheria, tetanus, pertussis acellular and Haemophilus influenzae type b (DTPa + Hib) vaccine was associated with the highest percentage of reactions (43.4%).
  • Common reactions included injection-site edema, pain, and fever; the measles, mumps, rubella (MMR) vaccine was linked to fever.

Conclusions:

  • Active surveillance effectively identifies adverse vaccine reactions often underreported in routine practice.
  • Primary care physicians and nurses play a vital role in vigilant monitoring and reporting of vaccine side effects.
  • Findings underscore the importance of ongoing pharmacovigilance in pediatric vaccination programs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
210
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
196
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
173
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Vaccinations01:51

Vaccinations

Overview
51.0K
Allergic Reactions02:06

Allergic Reactions

Overview
31.8K